Gain Therapeutics, Inc. Profile Avatar - Palmy Investing

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancemen…

Biotechnology
US, Bethesda [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Gain Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of GANX's Analysis
CIK: 1819411 CUSIP: 36269B105 ISIN: US36269B1052 LEI: - UEI: -
Secondary Listings
GANX has no secondary listings inside our databases.